AIM ImmunoTech (AIM) Cash & Equivalents (2010 - 2026)
AIM ImmunoTech (AIM) posted Cash & Equivalents of $9.9 million for Q2 2026, compared with $476,000 a year earlier and up 70.2% from the prior quarter.
Powered by 
Analysis
AIM ImmunoTech (AIM) Cash & Equivalents (2010 - 2026) Analysis & Trends
At the end of FY2025, AIM ImmunoTech's Cash & Equivalents came in at $2.99 million, up 75.5% from FY2024.
- Annual Cash & Equivalents shows a five-year compound annual growth rate of -40.0% (FY2020 to FY2025).
- In prior years, AIM ImmunoTech's Cash & Equivalents was $1.7 million in FY2024 (-68.7%), $5.44 million in FY2023 (-79.9%), $27.05 million in FY2022 (-15.7%) and $32.09 million in FY2021 (-16.6%).
- The Q2 2026 figure stands as the highest quarterly Cash & Equivalents since Q3 2023.
- On a year-over-year basis, Cash & Equivalents increased in three of the last seven quarters, with growth averaging 65.4%.
- The strongest year-over-year quarter for Cash & Equivalents in the past five years was Q1 2026, with growth of 547.7%; the weakest was Q3 2024, with a decline of 94.0%.
- According to Business Quant data, Cash & Equivalents for the three prior quarters was $5.82 million (Q1 2026), $2.99 million (Q4 2025) and $2.35 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 20.42 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 6.57 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 6.85 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 7.62 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 4.89 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 13.99 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 3.18 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 976.00 Mn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 6.14 Bn |
| 10 | AIM ImmunoTech | 3.08 Mn | -18.22 Mn | 21,000.00 | 9.90 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 9.90 Mn |
| Mar 31, 2026 | 5.82 Mn |
| Dec 31, 2025 | 2.99 Mn |
| Sep 30, 2025 | 2.35 Mn |
| Jun 30, 2025 | 476,000.00 |
| Mar 31, 2025 | 898,000.00 |
| Dec 31, 2024 | 1.70 Mn |
| Sep 30, 2024 | 915,000.00 |
| Jun 30, 2024 | 3.55 Mn |
| Mar 31, 2024 | 3.30 Mn |
| Dec 31, 2023 | 5.44 Mn |
| Sep 30, 2023 | 15.26 Mn |
| Jun 30, 2023 | 21.04 Mn |
| Mar 31, 2023 | 23.40 Mn |
| Dec 31, 2022 | 27.05 Mn |
| Sep 30, 2022 | 29.76 Mn |
| Jun 30, 2022 | 34.45 Mn |
| Mar 31, 2022 | 28.99 Mn |
| Dec 31, 2021 | 32.09 Mn |
| Sep 30, 2021 | 37.35 Mn |
API Access
AIM ImmunoTech Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=AIM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "AIM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=AIM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();